MaaT wraps up cancer microbiome trial early to power into phase 2/3 this year
MaaT wraps up cancer microbiome trial early to power into [...]
Alnylam touts data replication for next-generation Onpattro in ATTR trial but analysts pour some cold water
Alnylam touts data replication for next-generation Onpattro in ATTR trial [...]
MD Anderson inks deal to put Chinese cancer drugs through trials, starting with a PI3K inhibitor
MD Anderson inks deal to put Chinese cancer drugs through [...]
Kura exits FDA clinical hold after agreeing to mitigation measures, enabling resumption of blood cancer trial
Kura exits FDA clinical hold after agreeing to mitigation measures, [...]
CROs embracing tech to decentralize trials and speed enrollment as regulators show support ‘with their feet’
CROs embracing tech to decentralize trials and speed enrollment as [...]
Fresh from $86M series A, Metis poaches Kala CSO to support move into the clinic
Fresh from $86M series A, Metis poaches Kala CSO to [...]
Bloodletting at Zymeworks as new CEO axes half of senior leaders, plans 25% reduction in headcount
Bloodletting at Zymeworks as new CEO axes half of senior [...]
Fierce JPM Week: Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen’s Aduhelm
Fierce JPM Week: Confidence is high for Eli Lilly CEO [...]
Fierce JPM Week: As Novartis tries to avoid ‘me-too’ meds in M&A hunt, R&D chief urges biotechs to ‘please reach out’
Fierce JPM Week: As Novartis tries to avoid ‘me-too’ meds [...]
Charles River diving deeper into AI drug development in partnership with Valo Health
Charles River diving deeper into AI drug development in partnership [...]